To find metastatic recurrence biomarkers of TNBC treated by neoadjuvant chemotherapy and anti-EGFR antibodies, investigators evaluated tumor genomic, transcriptomic, and immune features, using MSK-IMPACT assay, gene arrays, Nanostring technology, and TIL assessment on H&E.
[npj Breast Cancer]
7992332
{7992332:AAAAAAAA}
apa
50
1
166903
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
